Back to results
US 12,691,144 B2Granted
Ovotransferrins for use in the treatment of iron deficiency anaemia
AssigneeBioseutica B.V.
InventorsValerio Maria Ferrari, Maria Carla Baggio, Paride Grisenti
Life of this patent
Estimating the term…
Abstract
Ovotransferrins with a degree of iron saturation from 0 to 15% are useful in the treatment of iron deficiency and iron deficiency anaemia, increasing the cell viability on gastric and intestinal cell models with respect to the holo-OvT 100%, when tested at the same concentrations, showing also a surprisingly better time dependent absorption of iron ions and a physiological trend allowing a single oral administration in 24 hours.
Claims5
A method of treating iron deficiency and iron deficiency anaemia in a subject in need thereof, said method comprising
- administering to said subject a pharmaceutical effective amount of ovotransferrin with an iron content from 1 ppm to 246 ppm.
Dependencies are inferred from the claim text.